Pauline Tully (Cavan-Monaghan, Sinn Fein) | Oireachtas source

I raise the matter of the drug Spinraza, which was approved in June 2019 for the treatment of spinal muscular atrophy. The roll-out has been very slow as only 12 of 29 children with this condition have so far received treatment. Spinal muscular atrophy is a degenerative disease and these continued delays have a real and psychological impact on children with the condition, who lose a little more motor function every day. Adults are not included in the roll-out of the drug. Will the Government address this matter and ensure all children and adults who need it can receive the drug?

See this speech in context